Press release
Market Driver Insights: The Impact of Recent Advances on the Enteric Disease Testing Market
Enteric Disease Testing Market
Projected Growth and Market Size of the Enteric Disease Testing Market
The enteric disease testing market is expected to reach $6.62 billion by 2030, growing at a steady compound annual growth rate (CAGR) of 6.3%. This upward trend is fueled by the widespread adoption of rapid testing methods, advancements in molecular diagnostics, and increased efforts toward outbreak preparedness. Additional factors contributing to growth include rising awareness about sanitation and the expansion of healthcare access globally. Key trends shaping this market include an increase in foodborne illnesses, growing demand for rapid diagnostic tests, broader use of stool-based diagnostics, enhancement of public health surveillance testing, and a stronger focus on early identification of pathogens.
Download a free report of the enteric disease testing market report:
https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Important Companies Leading the Enteric Disease Testing Market
Several prominent organizations play significant roles in the enteric disease testing industry. These include Becton dic*kinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, Meridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company, Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, and Veredus Laboratories Pte Ltd.
Expansion through Strategic Acquisitions in Enteric Disease Testing
In June 2023, Avacta Group plc, a UK-based firm specializing in diagnostic and life-science technologies, acquired Coris BioConcept SRL for $0.009 billion (£7.4 million) upfront with an additional earn-out potential of up to $0.004 billion (£3.0 million). This acquisition is intended to broaden Avacta's capabilities in enteric disease testing by incorporating Coris BioConcept's rapid lateral-flow and immunochromatographic diagnostic kits targeting gastrointestinal pathogens such as Giardia, Cryptosporidium, Clostridioides difficile, Helicobacter pylori, rotavirus, and adenovirus. Coris BioConcept, headquartered in Belgium, is known for producing rapid test kits for gastroenteric infections, respiratory pathogens, and antimicrobial resistance markers.
View the full enteric disease testing market report:
https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Factors Positively Impacting the Enteric Disease Testing Market
One major driver in this market is the continuous development of advanced digital health solutions, including remote monitoring platforms that enhance therapy management, reduce the frequency of in-person clinical visits, and improve patient safety. These remote-care technologies enable clinicians to track device performance, evaluate patient health, and adjust treatment settings in real time through connected apps.
A notable example occurred in April 2023 when Biotronik SE & Co. KG, a German medical technology company, received FDA approval for its Prospera spinal cord stimulation (SCS) system. This system features Embrace One, a cutting-edge remote-care model offering automatic, objective, and daily remote monitoring to provide continuous therapy oversight. The platform empowers healthcare providers to detect complications early, make remote therapy adjustments, and minimize the need for frequent clinic appointments. According to Biotronik, Embrace One facilitates proactive care, enhancing clinical decision-making and improving long-term patient outcomes.
Comprehensive Segment Breakdown of the Enteric Disease Testing Market
The report categorizes the enteric disease testing market based on several important criteria:
By Disease Type:
- Bacterial Enteric Disease
- Parasitic Enteric Disease
- Viral Enteric Disease
- Other Disease Types
By Technology:
- Traditional
- Rapid
- Convenience-Based
- Polymerase Chain Reaction (PCR)
- Immunoassay
- Chromatography and Spectrometry
- Other Technologies
By Application Area:
- Hospitals
- Research Centers
- Clinics
- Other Applications
Further subcategories within disease types include:
For Bacterial Enteric Disease: Salmonella, Escherichia coli (E. coli), Shigella, Campylobacter, Clostridium difficile (C. diff)
For Parasitic Enteric Disease: Giardia lamblia, Entamoeba histolytica, Cryptosporidium, Trichinella spiralis
For Viral Enteric Disease: Norovirus, Rotavirus, Adenovirus, Astrovirus
For Other Disease Types: Fungal enteric infections, foodborne illnesses, antibiotic-associated diarrhea
Regional Market Insights and Outlook
While the report primarily focuses on global trends, the market's expansion is expected to vary across regions due to differences in healthcare infrastructure, disease prevalence, and diagnostic adoption rates. Enhanced surveillance and testing in emerging markets present additional opportunities for growth over the coming years, complementing established demand in developed areas.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Market Driver Insights: The Impact of Recent Advances on the Enteric Disease Testing Market here
News-ID: 4476120 • Views: …
More Releases from The Business Research Company
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Fi …
The first aid training sector is on track for significant expansion, driven by evolving educational methods and increasing awareness about the importance of emergency preparedness. As more organizations and individuals seek accessible and effective training, the market is poised to experience noteworthy growth through 2030. Let's explore the current market size, key players, emerging trends, and the main segments shaping this industry.
Projected Market Size and Growth of the First Aid…
Leading Companies Reinforce Their Presence in the Fibrodysplasia Ossificans Prog …
The treatment landscape for fibrodysplasia ossificans progressiva (FOP) is evolving rapidly, driven by scientific breakthroughs and growing research investments. With new therapies emerging and a stronger focus on personalized medicine, the market for FOP treatments is set to expand significantly in the coming years. Below is a detailed overview of the market size, key players, industry trends, and segmentation shaping this specialized sector.
Projected Market Size and Growth Trajectory of the…
Emerging Growth Trends Driving Rapid Expansion in the Fertility Supplement Marke …
The fertility supplement market is gaining significant attention as more consumers seek effective solutions to support reproductive health. Innovations in formulations and a growing emphasis on preventive care are shaping this sector's rapid expansion. Let's explore the market size, key players, emerging trends, and the main segments that define this evolving industry.
Fertility Supplement Market Size and Growth Forecast Through 2030
The fertility supplement market is projected to experience robust growth,…
Analysis of Market Segmentation, Dynamics, and Competitive Landscape in the Feca …
The fecal transplant therapy market is gaining significant traction as it continues to evolve and expand. Innovations in treatment approaches and an increasing understanding of microbiome health are paving the way for new therapeutic options. Let's explore the market's size, key players, influential trends, and segmentation to better understand its future trajectory.
Fecal Transplant Therapy Market Size and Growth Outlook
The fecal transplant therapy market is projected to experience robust growth…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
